IronAxis

IronAxis Industrial Supply

IronAxis is a U.S.-based B2B supplier of industrial equipment, instruments, machinery, food processing systems and new energy solutions for manufacturers, labs and engineering companies.

Contact Us

[email protected]

picture1 picture2 picture3 picture4 picture5 picture6
Evonik Opens Largest Medical Device Technology Center Worldwide
Product Updates Online Sources 16 Dec 2025 views ( )

Evonik Opens Largest Medical Device Technology Center Worldwide

On July 9, Evonik inaugurated its largest global medical device technology center in Shanghai.

The center focuses on the research, development, and processing of semi-finished components for bioresorbable medical devices, serving the entire Asian market and helping customers address various challenges in innovating high-end medical devices.

The technology center will utilize advanced processing techniques to develop and produce various forms of semi-finished components using Evonik's standard and customized biomaterials as raw materials. These components can be tailored with specific properties such as bioresorbability, low friction coefficient, thrombosis resistance, and anti-bacterial adhesion, according to customer requirements. Medical device manufacturers can further process these components into final devices to meet specific needs across multiple clinical fields.

Summer Xia, President of Evonik Greater China, said, "Innovation in high-end medical devices is crucial for advancing the implementation of the 'Healthy China 2030' initiative. As the world's second-largest medical device market, China sees increasing emphasis among manufacturers on sourcing competitive materials and service solutions to stand out in this highly competitive landscape. Strategically, the Evonik Medical Device Technology Center in Shanghai closely aligns with these urgent market demands and will accelerate industrial upgrading."

The photo shows the opening ceremony. (Photo provided by the company)

Reposted for informational purposes only. Views are not ours. Stay tuned for more.